Financials Liquidia Corporation

Equities

LQDA

US53635D2027

Pharmaceuticals

Real-time Estimate Cboe BZX 10:16:08 2024-05-21 am EDT 5-day change 1st Jan Change
13.35 USD 0.00% Intraday chart for Liquidia Corporation +11.66% +11.01%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 79.76 127.8 253.1 410.8 822.8 1,020 - -
Enterprise Value (EV) 1 42.14 74 207.5 337.4 822.8 996.9 1,119 1,246
P/E ratio -1.65 x -1.68 x -6.96 x -9.51 x -9.94 x -10.4 x -33.7 x 61.4 x
Yield - - - - - - - -
Capitalization / Revenue 9.88 x 173 x 19.7 x 25.8 x 47.1 x 13.6 x 5.57 x 4.99 x
EV / Revenue 5.22 x 100 x 16.1 x 21.2 x 47.1 x 13.3 x 6.12 x 6.1 x
EV / EBITDA - - - -9.61 x -11.6 x -12.5 x 23 x -
EV / FCF -0.84 x -1.36 x -6.08 x -11.6 x - -15.9 x -135 x 33 x
FCF Yield -119% -73.4% -16.5% -8.65% - -6.3% -0.74% 3.03%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 18,657 43,336 51,978 64,495 68,397 76,383 - -
Reference price 2 4.275 2.950 4.870 6.370 12.03 13.35 13.35 13.35
Announcement Date 3/11/20 3/23/21 3/17/22 3/16/23 3/13/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 8.072 0.7396 12.85 15.94 17.49 75.21 182.9 204.2
EBITDA 1 - - - -35.12 -71.21 -79.64 48.6 -
EBIT 1 -46.82 -59.09 -33.8 -38.77 -73.38 -88.68 -19.58 30.44
Operating Margin -580.07% -7,989.01% -262.94% -243.3% -419.62% -117.91% -10.7% 14.9%
Earnings before Tax (EBT) 1 -47.58 -59.76 -34.58 -41.02 -78.5 -84.57 -11.18 28.55
Net income 1 -47.58 -59.76 -34.58 -41.02 -78.5 -97.39 -30.28 18.82
Net margin -589.48% -8,080.09% -269.02% -257.39% -448.89% -129.5% -16.56% 9.22%
EPS 2 -2.590 -1.760 -0.7000 -0.6700 -1.210 -1.289 -0.3957 0.2175
Free Cash Flow 1 -50.13 -54.33 -34.14 -29.18 - -62.83 -8.263 37.72
FCF margin -621.06% -7,345.59% -265.63% -183.12% - -83.54% -4.52% 18.47%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - 200.35%
Dividend per Share 2 - - - - - - - -
Announcement Date 3/11/20 3/23/21 3/17/22 3/16/23 3/13/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 3.215 3.492 3.918 3.165 5.36 4.493 4.786 3.678 4.531 2.972 9.8 18.03 30.17 38.16 48.54
EBITDA 1 - - - - -3.416 - - - - - -29 -15 -7.341 - -
EBIT 1 -11.36 -14.47 -8.97 -12 -6.497 -9.232 -22.82 -14.89 -26.44 -28.8 -24.24 -22.19 -15.28 -4.843 2.789
Operating Margin -353.42% -414.43% -228.94% -379.02% -121.21% -205.48% -476.91% -404.87% -583.45% -969.08% -247.37% -123.08% -50.65% -12.69% 5.75%
Earnings before Tax (EBT) 1 -11.56 -15.94 -9.447 -9.092 -6.533 -11.74 -23.52 -15.79 -27.45 -40.93 -22.53 -19.94 -9.668 -7.143 0.489
Net income 1 -11.56 -15.94 -9.447 -9.092 -6.533 -11.74 -23.52 -15.79 -27.45 -40.93 -25.07 -23.56 -16.22 -7.143 0.489
Net margin -359.66% -456.56% -241.12% -287.27% -121.88% -261.41% -491.37% -429.31% -605.83% -1,377.12% -255.78% -130.7% -53.78% -18.72% 1.01%
EPS 2 -0.2300 -0.3000 -0.1500 -0.1400 -0.0900 -0.1800 -0.3600 -0.2400 -0.4200 -0.5400 -0.3286 -0.3057 -0.2129 -0.0900 0.0100
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 3/17/22 5/12/22 8/11/22 11/8/22 3/16/23 5/4/23 8/10/23 11/7/23 3/13/24 5/13/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - 99.5 227
Net Cash position 1 37.6 53.8 45.6 73.4 - 22.8 - -
Leverage (Debt/EBITDA) - - - - - - 2.048 x -
Free Cash Flow 1 -50.1 -54.3 -34.1 -29.2 - -62.8 -8.26 37.7
ROE (net income / shareholders' equity) - - - -51.4% - -110% - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share 2 - - - -0.4700 - -1.080 0.0500 -
Capex 1 1.85 0.75 0.11 0.59 - 1.42 1.43 1.45
Capex / Sales 22.92% 101.68% 0.83% 3.72% - 1.88% 0.78% 0.71%
Announcement Date 3/11/20 3/23/21 3/17/22 3/16/23 3/13/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
13.35 USD
Average target price
24.14 USD
Spread / Average Target
+80.85%
Consensus
  1. Stock Market
  2. Equities
  3. LQDA Stock
  4. Financials Liquidia Corporation
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW